ROZA 1% + 2% CREAM – 2026 Price Turkey

by

Clinical Data Review: Comprehensive profile for ROZA 1% + 2% CREAM, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: ROZA 1% + 2% CREAM

Manufacturer: ORVA ILAC SAN. AND TRADE Inc.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

METRONIDAZOL
URE 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

ROZA 1% + 2% CREAM is formulated with METRONIDAZOL
URE, a clinically established agent in medical practice.

  • Mechanism of Action: METRONIDAZOL
    URE acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to METRONIDAZOL
    URE     therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name ROZA 1% + 2% CREAM
Barcode (GTIN) 8699561350147
Generic Name METRONIDAZOL
URE
License Holder ORVA ILAC SAN. AND TRADE Inc.
Pharmacy Retail Price 75.45 TL
⚠️ Clinical Safety Warning

Do not administer ROZA 1% + 2% CREAM if the patient has a known hypersensitivity or allergy to METRONIDAZOL
URE. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via ORVA ILAC SAN. AND TRADE Inc..

Leave a Comment